Oral isotretinoin and pregnancy prevention programmes

Br J Dermatol. 2012 Feb;166(2):466-7; author reply 467-8. doi: 10.1111/j.1365-2133.2011.10686.x. Epub 2012 Jan 9.
No abstract available

Publication types

  • Letter
  • Comment

MeSH terms

  • Abnormalities, Drug-Induced / prevention & control*
  • Dermatologic Agents / adverse effects*
  • Female
  • Guideline Adherence*
  • Humans
  • Isotretinoin / adverse effects*
  • Pregnancy
  • Teratogens*

Substances

  • Dermatologic Agents
  • Teratogens
  • Isotretinoin